FDA accepts NDA for SHIONOGI's application 220442
The FDA has accepted the New Drug Application (NDA) 220442 submitted by Shionogi Inc. for review.
Asset / Drug
Drug and asset intelligence for NDA220442 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.